Classes
Publications
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk lowering2016 | First Faculty of Medicine
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy2015 | First Faculty of Medicine
- Plant sterols and stanols: not yet own recommendations for diet enrichment targeted reduction of LDL - cholesterol and cardiovascular risk2015 | First Faculty of Medicine
- Dyslipidemia in 20122012 | First Faculty of Medicine
- Lifestyle modification induced weight loss and changes of cardiometabolic risk factors including lowering of inflammatory response in obese children2011 | First Faculty of Medicine
- Hypolipidemic therapy in the hands of a general practitioner2011 | First Faculty of Medicine
- The importance of lipid-lowering therapy2011 | First Faculty of Medicine
- The role of omega-3 fatty acids in the treatment of risk factors of cardiovascular disease in menopausal women2010 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- Comprehensive management of cardiovascular risk. Focusing on telmisartan2010 | First Faculty of Medicine
Loading network view...